Pancreatic Cancer Research

ResearcherStanford MedicineActive in the last 2 years

Calvin Jay Kuo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7427-5985; OpenAlex author ID A5056685479. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
33
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper

Papers 6

  1. Engineered matrices reveal stiffness-mediated chemoresistance in patient-derived pancreatic cancer organoids. Co-author DOI 10.1038/s41563-024-01908-x↗
  2. Complete Remission of Widely Metastatic Human Epidermal Growth Factor Receptor 2-Amplified Pancreatic Adenocarcinoma After Precision Immune and Targeted Therap… Last author DOI 10.1200/po.21.00489↗
  3. Pharmacologic Targeting of TFIIH Suppresses KRAS-Mutant Pancreatic Ductal Adenocarcinoma and Synergizes with TRAIL. Co-author DOI 10.1158/0008-5472.can-21-4222↗
  4. CHK1 protects oncogenic KRAS-expressing cells from DNA damage and is a target for pancreatic cancer treatment. Co-author DOI 10.1016/j.celrep.2021.110060↗
  5. Complete remission in a patient with widely metastatic HER2-amplified pancreatic adenocarcinoma following multimodal therapy informed by tumor sequencing and o… Last author DOI 10.1101/2021.12.16.21267326↗
  6. Personalizing pancreatic cancer organoids with hPSCs. First author DOI 10.1038/nm.3992↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. George A. Poultsides · 2 shared papers, 2021–2023 · strength 0.21
  2. William Arthur Hoos · 2 shared papers, 2021–2023 · strength 0.21
  3. Joseph M. Herman · 2 shared papers, 2021–2023 · strength 0.21
  4. Michele Cioffi · 2 shared papers, 2021–2023 · strength 0.21
  5. Daniel Tandel Chang · 2 shared papers, 2021–2023 · strength 0.21
  6. Daniel A. King · 2 shared papers, 2021–2023 · strength 0.21
  7. George Albert Fisher · 2 shared papers, 2021–2023 · strength 0.21
  8. William E. Gillanders · 2 shared papers, 2021–2023 · strength 0.21
  9. Bauer L. LeSavage · 1 shared paper, 2024 · strength 0.17
  10. Sarah C. Heilshorn · 1 shared paper, 2024 · strength 0.17
  11. Russell D. Moser · 1 shared paper, 2022 · strength 0.13
  12. Rosalie C. Sears · 1 shared paper, 2022 · strength 0.13
  13. Haiyong Han · 1 shared paper, 2022 · strength 0.13
  14. Christopher J Kemp · 1 shared paper, 2022 · strength 0.13
  15. Andrew Victor Biankin · 1 shared paper, 2022 · strength 0.13
  16. Daniel D. Von Hoff · 1 shared paper, 2022 · strength 0.13
  17. Haiyu Zhang · 1 shared paper, 2015 · strength 0.11
  18. Jonathan M. DeLiberty · 1 shared paper, 2021 · strength 0.09
  19. Kristina Drizyte‐Miller · 1 shared paper, 2021 · strength 0.09
  20. Bjoern Papke · 1 shared paper, 2021 · strength 0.09
  21. Ye S. Lee · 1 shared paper, 2021 · strength 0.09
  22. Emanuel F. Petricoin · 1 shared paper, 2021 · strength 0.09
  23. J. Nathaniel Diehl · 1 shared paper, 2021 · strength 0.09
  24. Mariaelena Pierobon · 1 shared paper, 2021 · strength 0.09
  25. Kirsten L. Bryant · 1 shared paper, 2021 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.